Listar MED_Articles por autoría "a685aaaa-32ed-4b7a-83e2-cca666464d7b"
Mostrando ítems 1-1 de 1
-
Comparison of baseline clinical characteristics among people with type 2 diabetes on second-line therapy previously added with dapagliflozin or another oral glucose-lowering drug: AGORA study
Pallarés-Carratalá, Vicente; Ruiz-García, Antonio; Serrano-Cumplido, Adalberto; Segura Fragoso, Antonio; Fernández-Pascual, Verónica; Sánchez-Sánchez, Beatriz; Cervera-Pérez, María Inmaculada; Alonso-Moreno, Francisco Javier; Arranz, Ezequiel; barquilla garcía, alfonso; Rey Aldana, Daniel; Polo García, José Luis; Cinza-Sanjurjo, Sergio; Spanish Society Primary Care Physicians SEMERGEN Foundation Elsevier (2024)Introduction: Type 2 diabetes mellitus (T2D) has acquired epidemic proportions worldwide. In recent years, new oral glucose-lowering drugs (OGLD) have emerged that improve the cardiovascular---kidney---metabolic control ...